Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heart failure
heart failure
Study Data Show Abbott's CardioMEMSDevice Can Improve Care for More Patients with Heart Failure
Drugs.com
Sun, 08/29/21 - 11:19 pm
Abbott Labs
clinical trials
CardioMEMS
heart failure
devices
Here's What This Label Expansion Could Mean for Eli Lilly Investors
Motley Fool
Sun, 08/29/21 - 11:16 pm
Eli Lilly
Jardiance
heart failure
label expansions
FDA
Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial
Fierce Biotech
Wed, 08/25/21 - 11:15 am
Cardior
antisense
heart failure
Bristol Myers Squibb
funding
Eli Lilly, Boehringer Ingelheim tout pivotal heart failure win for Jardiance, potentially setting up a Novartis showdown
Endpoints
Tue, 07/6/21 - 10:52 am
Eli Lilly
Boehringer Ingelheim
heart failure
clinical trials
Jardiance
AZ drug for hard-to-treat heart failure has mixed results in trial
Pharmaforum
Fri, 07/2/21 - 10:59 am
AstraZeneca
heart failure
clinical trials
AZD4831
Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance
Pharmaforum
Wed, 06/23/21 - 10:59 am
AstraZeneca
Farxiga
heart failure
Boehringer Ingelheim
Eli Lilly
Jardiance
Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure
Endpoints
Fri, 06/11/21 - 10:56 am
heart failure
Heartseed
Japan
Novo Nordisk
stem cells
ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients
Fierce Pharma
Sat, 05/15/21 - 11:00 pm
ACC
Novartis
Entresto
heart failure
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
Mon, 04/12/21 - 10:33 am
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Fierce Pharma
Tue, 02/16/21 - 11:40 pm
Novartis
Entresto
heart failure
labeling
FDA
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Pharmaforum
Tue, 01/12/21 - 10:50 am
Boehringer Ingelheim
Eli Lilly
Jardiance
FDA
heart failure
fast track
Novartis' heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?
Fierce Pharma
Wed, 12/16/20 - 11:35 am
Novartis
Entresto
heart failure
heart failure with preserved ejection fraction
Will Vectorious Be Victorious in Heart Failure?
Medical Devices and Diagnostics Industry
Wed, 12/2/20 - 10:47 am
devices
Vectorious Medical Technologicies
breakthrough device
FDA
left atrial pressure sensor
heart failure
AHA 2020 – sotagliflozin wins come too late for Lexicon
EP Vantage
Tue, 11/17/20 - 10:45 am
Lexicon Pharmaceuticals
sotagliflozin
AHA
heart failure
chronic kidney disease
AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
Mon, 11/16/20 - 10:13 am
AHA
Omecamtiv Mecarbil
Amgen
Cytokinetics
heart failure
Boehringer, Yale trial digital tech in heart failure
Pharmaforum
Fri, 10/16/20 - 11:08 am
Boehringer Ingelheim
Yale
digital therapeutics
digital health
heart failure
ESC: Merck's Steglatro shows limited promise with heart failure hospitalization data
Fierce Pharma
Mon, 08/31/20 - 10:44 am
Merck
Steglatro
ESC
heart failure
ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one
Fierce Pharma
Mon, 08/31/20 - 10:20 am
Novartis
Entresto
ESC
heart failure
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
Mon, 08/31/20 - 10:13 am
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
BioSpace
Fri, 07/31/20 - 10:40 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
diabetes
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »